The FSP’s 48th Annual Pathology Conference: Updates and Practical Approaches in Pathology will provide pathologists with education surrounding a wide range of topics and the opportunity to learn and adopt new strategies and tools to aid in the diagnosis and analysis of diseases.
The conference will provide practical updates and clinical pearls and pitfalls in the following topics:
In addition, there will be education on additional topics during interactive read slides and microscopy sessions.
New This Year!
We are excited to announce that there will be a Rare and Interesting Case Session where community pathologists, junior faculty and trainees wtih a faculty mentor will be invited to submit their cases for presentation. Five cases will be chosen. More details will be forthcoming!
|Abstract Poster Submission #1|
|Disclosure of Funding Support|
|Choose one of the following Topics|
Jonathan Epstein, MD
Professor of Pathology, Urology, Oncology
Johns Hopkins Medicine
Topic: GU Pathology
Elizabeth Anne Montgomery, MD
Professor of Pathology
University of Miami
Topic: GI Pathology
Bruce M. Wenig, MD
Chair and Senior Member, Department of Pathology
Moffitt Cancer Center
Topic: Head and Neck Pathology
David Andrews, MD
Associate Professor, Department of Pathology and Laboratory Medicine
University of Miami Miller School of Medicine
Topic: COVID-related laboratory activities (variant tracking initiative)
Aziza Nassar, MD, MPH, MBA
Chair and Professor, Pathology and Laboratory Medicine
Mayo Clinic and Foundation
Topic: Breast Pathology Microscopy Session
Zehra Ordulu, MD
Assistant Professor, Department of Pathology, Immunology and Laboratory Medicine
University of Florida
Topic: GYN Pathology Microscopy Session
Elham Nasri, MD
Clinical Assistant Professor
University of Florida
Topic: What is new in the world of undifferentiated small round cell tumors
Marie L. Rivera-Zengotita, MD
Neuropathology Unit Director
Clinical Associate Professor
University of Florida
Topic: Mesenchymal-type tumors of the CNS: Revisiting the oldies and introducing new entities from the 2021 WHO classification
Brian Stewart, MD
Clinical Assistant Professor
University of Florida
Topic: Poorly Differentiated Lung Tumors: When TTF-1/Napsin-A and p40 aren’t enough
Ronald Giffler, MD
Florida Medical Association
President and CEO
Fort Lauderdale, FL
Emily Volk, MD, MBA, FCAP
College of American Pathologists
San Antonio, TX
Disney’s Grand Floridian Resort & Spa
4401 Floridian Way
Lake Buena Vista, Florida 32830
Room Rate: $329/night (plus tax)
To reserve your sleeping room you must FIRST register for the meeting. You will receive a special code and the reservations link to reserve your room after you have registered for the FSP Conference.
Victorian elegance meets modern sophistication at this lavish Disney Resort hotel. Relax in the sumptuous lobby as the live orchestra plays ragtime, jazz and popular Disney tunes. Unwind outdoors, indulge in a luxurious massage and watch evening fireworks light up the sky over Cinderella Castle. Just one stop to Magic Kingdom park on the complimentary Resort Monorail, this timeless Victorian-style marvel evokes Palm Beach’s golden era.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and the Florida Society of Pathologists. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.
The Florida Medical Association designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CRITERIA FOR SUCCESS
Statements of credit/participation will be awarded based on the participant’s attendance at each session and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claim credit form at www.flpath.org/claimcme. If you have questions about this CME/CE activity, please contact the FSP at 904-309-6261. Credit must be claimed by March 2, 2022.
This activity is designed to meet the needs of practicing physicians, pathologists, and other specialists involved with pathology.
STATEMENT OF NEED
The field of pathology is constantly changing, and many of the most important advances in the field. In the setting of new technology, techniques and advancements in the field, practice gaps are inevitable. As such, pathologists require ongoing educational opportunities to stay current in order to maintain and improve their knowledge and competence in the field.
At the conclusion of this activity, all participants should be able to:
COMMERCIAL SUPPORT AND EDUCATIONAL GRANTS
At the time of this printing, full commercial support and educational grant information was not available. All commercial support and educational grants will be communicated to attendees in advance of the meeting.
FACULTY AND PLANNER DISCLOSURES
Exhibitors at the 2022 FSP Annual Pathology Conference will connect with over 250 pathologists and engage in over 15 hours of face-to-face time with attendees.
Other benefits include:
We feel that the quality of speaker presentations, discussions, and organization at FSP is phenomenal. We look forward to attending in 2022.
The 2021 FSP Meeting has been one of the best meetings I have attended as an exhibitor. The atmosphere is very welcoming as an exhibitor. I feel part of the meeting as opposed to an outsider. It is an atmosphere where I have felt we are one with the pathologists working together to help their patients – Cindy S. May, MT (ASCP)
A great conference from all aspects. We met very interesting people and had good conversations. Good flow to conference. Very organized. Will be back next year!
– Michigan Medicine Labs
College of American Pathologists (CAP) House of Delegates Reception
Saturday, February 19
6:00 pm - 7:30 pm
Join the Florida Delegation for the College of American Pathologists (CAP) House of Delegates Reception in St. Augustine A at the conference center on Saturday, February 19 from 6:00-7:30 pm. Drinks and light appetizers will be available for your enjoyment. This reception is a chance to network with the Florida Delegation and CAP leadership. The Florida Delegation welcomes your ideas and thoughts on the important issues facing you and your practice.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.
Aiforia equips pathologists and scientists in preclinical, academic, and clinical labs with the most powerful deep learning artificial intelligence and cloud-based technology to increase the speed, accuracy and consistency of analyzing large and complex medical images across a variety of fields from oncology to neuroscience. Aiforia is composed of an ideal mix of scientists experienced in a variety of medical areas from pathology to cancer diagnostics, software developers who collectively hold over 100 years’ experience in artificial intelligence, and a business team with backgrounds in the pharmaceutical and biotechnology industries.
APS Medical Billing is a premier billing firm that provides expert billing and practice management solutions to pathology and laboratory practices nationwide. APS’ clients range in size from a single-physician practice to large, multi-site academic departments, reference and independent labs. The scope of our billing services and proven strategies allow APS to effectively bill for professional, technical and global components of anatomic and clinical pathology services. Please visit our website at www.apsmedbill.com.
Our ambition is to push the boundaries of science to change the practice of medicine and transform the lives of cancer patients. We target the underlying biology of cancer in Immuno-Oncology, Tumor Drivers/Resistance, DNA Damage Response and Antibody Drug Conjugates. Utilizing precision medicine and biomarker-driven indications we look to dramatically improve five-year survival. Our focus on early disease stages and relapsed patients is to 1) identify and treat patients earlier with curative intent; and 2) support relapsed and refractory patients by tackling primary or acquired resistance.
Caris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit www.CarisLifeSciences.com or follow us on Twitter (@CarisLS).
Cleveland Clinic Laboratories is dedicated to providing high-quality, clinically impactful pathology and laboratory diagnostic services combined with readily available consultation from experienced pathologists and laboratory scientists. Our laboratories offer excellence in coagulation, flow cytometry, hematopathology, molecular testing and cytogenomics, and microbiology as well as subspecialty services in anatomic pathology. This approach ensures that every specimen submitted will be evaluated by a pathologist with a high level of diagnostic expertise in that specific field of pathology.
As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide.
CSI Laboratories is a cancer diagnostics laboratory known for its quality, state-of-the-art laboratory facility, and experienced staff. Our in-house medical team works closely with pathologists, oncologists, and technicians to provide comprehensive global and technical laboratory results throughout the United States. CSI Laboratories offers a full range of comprehensive cancer tests including flow cytometry, cytogenetic analysis, FISH, immunohistochemistry, molecular genetics, and consultations in the areas of hematopathology and surgical pathology.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Streamline workflow efficiencies and processes, eliminate errors and provide the best patient care with healthcare solutions from General Data. With our broad range of resources, including solutions for histology, positive patient identification, mobility, data capture and labeling, hospital and laboratory staff can use these technologies to do what they do best: deliver optimal outcomes and the best possible care.
GenPath Oncology provides leading expertise in cancer diagnostics and offers a comprehensive portfolio to provide a single source solution laboratory for cancer patients’ needs. GenPath is backed by a team of specialized pathologists and has experience in providing diagnostic oncology solutions, from routine clinical and special coagulation testing to complex genomic testing for tumor sequencing and hereditary cancer syndromes. GenPath offers oncologists and pathologists a variety of diagnostic solutions including morphological analysis, immunohistochemistry, FISH, flow cytometry, karyotyping, molecular analysis, and next generation sequencing.
ImagineSoftware is the leading provider of medical billing automation software and revenue cycle management applications. Offering powerful technology solutions for medical billing offices, practices, and hospitals for over 21 years, ImagineSoftware currently serves more than 48,000 physicians. ImagineSoftware solutions improve financial efficiency, build provider reputation, and ultimately improve the patient experience. For more information, visit ImagineTeam.com and follow us on Twitter @ImagineTeam.
Innovative Science Press believes that all physicians deserve access to quality and affordable medical training to help their patients. For this reason, our books are written by some of the most prominent in the field and are reasonably priced. Although there are many excellent sources for learning diagnostic pathology, those directed at residents, fellows, and practicing pathologists, are too simplified to be practical for daily work, and many other texts assume a foundation of more knowledge than many of us have as we begin to learn about a new area of diagnostic pathology. The pathology survival guides aim to help not only residents and fellows but also practicing pathologists who begin to tackle an organ system unfamiliar to them or refresh knowledge on a particular topic. These volumes are practical, concise, and full of excellent illustrations.
Molecular testing for indeterminate thyroid nodules are not all the same. ThyGeNEXT / ThyraMIR is the only testing platform that utilizes both mutational and microRNA markers to aid patient management. MicroRNA classification complements cytology and mutational analysis as well as risk-stratified patients with weak driver mutations, including RAS.
MagMutual is a provider of Medical Malpractice insurance and practice solutions, including patient safety services to over 25,000 physicians and hospitals.
MedReceivables Advisor, LLC is a full service outsourcing medical billing company for the hospital based physician. Our company provides complete accounts receivable management services for hospital-based physicians.
As a CLIA-certified/CAP accredited full-service laboratory of over 30 years, Michigan Medicine Laboratories combines the scientific rigor and infrastructure investment of a top academic research institution with the efficiency, flexibility, and responsiveness of a private reference lab. Our menu consists of over 1,800 tests and 60 expert consultants within 18 subspecialties available across the country. Partnering with Michigan Medicine Laboratories means gaining acces to one of the largest, most productive pathology enterprises in academic medicine, with faculty equally passionate about scientific discovery and service excellence. By making nationally recognized faculty and state-of-the-science technology easily accessible, we help you meet your practice's needs for on-time, accurate pathology results.
Management Services Network, LLC (MSN) is a privately held company that provides comprehensive and proactive billing, accounts receivable and practice management services to radiology practices nationwide. The breadth and depth of MSN's experience and involvement in the radiology environment provides clients with confidence, trust and results. MSN provides services beyond the typical billing company, such as patient satisfaction surveys, and has also been approved by CMS as a Qualified Clinical Data Registry (QCDR) for MIPS measure creation, submission and reporting. Learn more at msnllc.com.
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and wellbeing for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease.
Signatera™ is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for cancer management.
NeoGenomics is a Florida-based premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic, and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the US and offer global capabilities with laboratories in Switzerland and Singapore.
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. We serve half of the physicians and hospitals in the United States.
Our goal is to build awareness around an aggressive and deadly hematologic malignancy called Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). There is a newly approved therapy for BPDCN and we aim to shorten the time to diagnosis so patients can be placed on appropriate therapy in a timely manner.
Vachette provides revenue strategy, revenue consulting and revenue insurance for independent laboratories, hospital outreach laboratories, esoteric laboratories, private pathology practices, individual hospitals and health systems.
Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve patient care when diagnostic test results are uncertain. Our tests leverage innovations in genomic technology and machine learning to enable a significantly more confident diagnosis than currently possible in challenging diseases such as thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. We are creating new standards of care in the diagnosis of these diseases by enabling more patients to avoid unnecessary invasive procedures, speeding time to diagnosis and removing costs from the healthcare system.
The Florida Society of Pathologists (FSP) Poster Review Committee invites the submission of posters for inclusion in the Poster Hall during the FSP’s Annual Pathology Conference taking place on February 18-20, 2022 at Disney’s Grand Floridian Resort & Spa. The purpose of the FSP Poster Hall is to stimulate research, provide a venue to share innovative and effective educational programs, showcase unique research projects, and to encourage networking among pathologists.
Who Can Submit?
All pathologists are invited to submit case-based posters or research-based posters for inclusion in the Poster Hall. Residents and fellows are eligible to compete in the FSP Poster Competition for prizes.
Poster Submission Deadline
January 7, 2022
11:59 pm EST
Poster Competition Eligibility
Residents and fellows who are enrolled in a full-time approved training program in pathology or sub-specialty of pathology in the state of Florida are invited to submit and are eligible to participate in the FSP Poster Competition.
Poster Competition Presentation Process and Awards
Posters will be pre-judged and selected by FSP judges based on quality, innovation, approach/design, and visuals. Posters will be judged twice and are subject to an additional preliminary review to determine eligibility. If judges deem that changes need to be made for posters to be eligible for presentation, lead authors will be contacted by email. The first judging will be done before the conference, and it will be a blind review. The second judging will be conducted during the live poster sessions during the conference on either Friday, February 18 or Saturday, February 19. The scores from both judging sessions will be combined to determine the winners. The first-place winner will receive $500, the second-place winner will receive $250, and the third-place winner will receive $150.
To be considered for the Poster Competition and awards, you must:
Winners of the Poster Competition will be announced, and prizes will be awarded during the FSP Business Meeting on Saturday, February 19, 2022.
Poster Submission Instructions
Please read through the submission instructions below before preparing your poster:
General Information and Policies:
Poster entries can only be accepted electronically and must adhere to the following guidelines:
You will be asked for the following:
The online poster submission does not allow you to save and return to resume later. Therefore, before starting your submission, have all materials and information ready. After the poster is submitted, you will receive an automated email to confirm your submission. If you do not receive the email within 24 hours, please contact the FSP office at firstname.lastname@example.org or call Erin Corrales at 904-309-6204.
The poster must relate to an appropriate topic in the field of pathology. Poster authors will be required to indicate which topic BEST matches the content of their poster. Topics are:
Please note, you will be required to use the pre-approved poster template for your poster submission. To download the templates click on the links below:
The FSP will not be responsible for submissions not received via the website or for submission errors caused by Internet service outages, hardware or software delays, power outages, or unforeseen events. Faxed, emailed or mailed hard-copy posters or posters sent on a CD/disc WILL NOT be accepted. If you have questions, please contact the FSP office at email@example.com or call 904-309-6204.
Pathology is hard! Every day, we are faced with challenging cases that require us to open books, read new articles, consult our friends and colleagues, and sometimes consult the experts. This year we are introducing something new for our annual FSP meeting to highlight these interesting cases and we need your help!
Community pathologists, junior faculty, and trainees with a faculty mentor are all encouraged to submit their rare and interesting cases for a chance to present at the FSP 2022 Annual Meeting.
How to submit a case
Please submit the information below as a short word document to firstname.lastname@example.org by December 9, 2021.
FSP Member Login